Open original FDA record ↗Recall record
- FDA identifier
- Z-0102-2015
- Company in FDA record
- Siemens Healthcare Diagnostics, Inc
- FDA classification date
- Oct 21, 2014
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Increased imprecision and positive bias is observed with patient samples and negative controls and can result in an increase in initial reactive results.
Source facts
- Action
- Siemens Healthcare issued An Urgent Medical Device Recall (UMDR) sent to all affected Siemens Healthcare Diagnostics customers in the United States on September 15, 2014. An Urgent Field Safety Notice (UFSN) was sent out for distribution to all customers outside the United States on September 15, 2014. These notices inform the customer of the imprecision and positive bias and a potential increase in initial reactive results associated with ADVIA Centaur Systems HBc Total Lot 100064. Customers were instructed to discontinue use of the affected lots and dispose of the product according to local regulations or procedures. The notices should be reviewed with the facility's laboratory or medical director. Each customer will be required to return a completed confirmation fax-back to Siemens.
- Initiated
- 2014-09-15
- Root cause
- Unknown/Undetermined by firm
- Terminated
- 2015-12-28
- Distribution
- Worldwide Distribution-USA (nationwide) and the countries of Austria Bahrain Belgium Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Great Britain Greece Hungary Iraq Ireland Italy Jordan Latvia Lebanon Lithuania Luxembourg Netherlands Norway Poland Portugal Romania Slovakia Spain Sweden Switzerland Turkey Unit.Arab Emir and Yemen.
- Recall number
- Z-0102-2015
- Recall status
- Terminated
- CDRH record ID
- 130181
- FDA classified
- 2014-10-21
- Recall event number
- 69292